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ABSTRACT

Basic helix-loop-helix (bHLH) proteins belong to a large family of transcription
factors that are known to play important roles in cell proliferation, differentiation
and oncogenesis.

These proteins are structurally featured by a bHLH motif,

which is responsible for protein dimerization and sequence-specific DNA binding
(e.g., E-box). Recently we isolated a cDNA from a human liver library by a gene
trapping method. Based on the Kozak rule, this cDNA encodes a protein with
415 amino acids, which is hereafter designated as CCAF. The objective of this
thesis is to establish the molecular mass of this protein and to test the hypothesis
that CCAF is a transcriptional modulator involving the regulation of cell cycle
events.

To establish the molecular mass, CCAF was in vitro translated with TNT
reticulocyte lysate and analyzed by autoradiography.

Addition of the CCAF

cDNA to the reaction mixture yielded a single product with a molecular weight of
52 kDa. This mass is consistent with the estimated weight and suggests that the
Kozak favorable sequence indeed harbors the codon for translation initiation. In
order to determine whether CCAF undergoes posttranslational modifications,
immunochemical experiments were performed. An antibody was raised against
a peptide derived from CCAF and subjected to affinity chromatography.

This

antibody detected a 52-kDa protein in the CCAF cDNA transfected cells but not
in the control cells. These results further support the notion that the functional
CCAF is a 52-kDa protein and undergoes little post-translational modifications.
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To determine the expression of CCAF in different cell growing states, OLD cells
derived from colon carcinomas were seeded at different densities. Likewise, this
antibody detected the 52-kDa protein in the cells plated at all densities.
However, proliferating cells expressed higher levels (-3-5 folds) than the
quiescent cells.
carcinomas.

These studies were further extended to human colon

Both Northern and Western blotting analyses detected abundant

expression of CCAF in the carcinomas but not in the nearby normal tissues.
These findings suggest that CCAF involves the regulation of cell cycle events
and contributes to the oncogenic pathogenesis.

To determine the activity of CCAF in transcription regulation, transient
cotransfection experiments were conducted with an E-box reporter. CCAF alone
caused little change on the reporter enzyme activity.

However, CCAF

antagonized by 30% the transactivation activity conferred by E4 7, a bHLH protein
that is known to transactivate E-box reporter. The antagonism on E47-mediated
transactivation activity and the differential expression relating to cell growing and
oncogenic states support the hypothesis that CCAF is a transcriptional modulator
that involves the regulation of cell cycle events and plays a role in oncogenic
pathology.
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ABSTRACT

Basic helix-loop-helix (bHLH) proteins belong to a large family of transcription
factors that are known to play important roles in cell proliferation, differentiation
and oncogenesis.

These proteins are structurally featured by a bHLH motif,

which is responsible for protein dimerization and sequence-specific DNA binding
(e.g., E-box). Recently we isolated a cDNA from a human liver library by a gene
trapping method. Based on the Kozak rule, this cDNA encodes a protein with
415 amino acids, which is hereafter designated as CCAF. The objective of this
thesis is to establish the molecular mass of this protein and to test the hypothesis
that CCAF is a transcriptional modulator involving the regulation of cell cycle
events.

To establish the molecular mass, CCAF was in vitro translated with TNT
reticulocyte lysate and analyzed by autoradiography.

Addition of the CCAF

cDNA to the reaction mixture yielded a single product with a molecular weight of
52 kDa. This mass is consistent with the estimated weight and suggests that the
Kozak favorable sequence indeed harbors the codon for translation initiation. In
order to determine whether CCAF undergoes posttranslational modifications,
immunochemical experiments were performed. An antibody was raised against
a peptide derived from CCAF and subjected to affinity chromatography.

This

antibody detected a 52-kDa protein in the CCAF cDNA transfected cells but not
in the control cells. These results further support the notion that the functional
CCAF is a 52-kDa protein and undergoes little post-translational modifications.
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To determine the expression of CCAF in different cell growing states, OLD cells
derived from colon carcinomas were seeded at different densities. Likewise, this
antibody detected the 52-kDa protein in the cells plated at all densities.
However, proliferating cells expressed higher levels (-3-5 folds) than the
quiescent cells.
carcinomas.

These studies were further extended to human colon

Both Northern and Western blotting analyses detected abundant

expression of CCAF in the carcinomas but not in the nearby normal tissues.
These findings suggest that CCAF involves the regulation of cell cycle events
and contributes to the oncogenic pathogenesis.

To determine the activity of CCAF in transcription regulation, transient
cotransfection experiments were conducted with an E-box reporter. CCAF alone
caused little change on the reporter enzyme activity.

However, CCAF

antagonized by 30% the transactivation activity conferred by E47, a bHLH protein
that is known to transactivate E-box reporter. The antagonism on E4 ?-mediated
transactivation activity and the differential expression relating to cell growing and
oncogenic states support the hypothesis that CCAF is a transcriptional modulator
that involves the regulation of cell cycle events and plays a role in oncogenic
pathology.
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INTRODUCTION

Transcription factors are proteins that initiate and modulate transcription rate by
interacting with specific DNA recognition sequences in the target genes.

As

shown in Fig. 1, these DNA-binding transcription factors are structurally classified
into four major classes: Helix-turn-helix homeodomain (e.g. PBX1 ), C2 H2 zinc
finger (e.g., Sp1 ), Helix-loop-helix (e.g ., c-myc) and Leucine zipper (e.g. , c-fos
and c-jun). Many other transcription regulators fall into none of these classes.
Therefore, a better classification system needs to be developed.

NH 1

Helix-turn-helix

Zinc finger

=1 ~:..
-~ r~:

/,. ,,
4:. .~

NH,

'

NH 1

Helix-loop-helix

Leucine zipper

Figure 1. Classification of transcription factors
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Basic helix-loop-helix (bHLH) proteins belong to a family of well-characterized
transcription factors. They play important roles in the control of cell proliferation
and differentiation that are involved in organ development and oncogenesis. For
example, they function in myogenesis (Myo0/E47), neurogenesis (NeuroD,
Achaete-scute/Oaughterless), tumorgenesis (Myc/Max) and sex determination
(E12/Da/ESC) (Little et al., 1998). In addition, these proteins are also involved in
immunoglobulin gene regulation (TFEC/TFE3) (Zhao et al., 1993), phospholipid
and pigment metabolism (lno2/Delila) (Nikoloff et al., 1992, Goodrich et al.,
1992), and xenobiotic response (AHR/ARNT) (Hirose et al., 1996).

I. Common Features of bHLH Proteins

1. Structural characteristics of bHLH proteins
bHLH proteins are distinguished by their bHLH domain, which was first identified
in an immunoglobulin enhancer-binding polypeptide and several other proteins
(e.g. Daughterless, MyoD and myc) (Murre et al., 1989). The bHLH domain is
divided into two functional subdomains: a Helix-loop-helix (HLH) subdomain and
an adjacent basic region. The HLH subdomain consists of two short amphipathic
a-helices separated by a non-conserved loop with various lengths and primarily
mediates the dimerization between HLH proteins (Voronova et al., 1990). The
basic region consists of a cluster of 10-20 amino acids rich in lysine and arginine
residues and is responsible for sequence-specific DNA binding (Burley, 1994 ).
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In addition to the bHLH domain, some proteins contain other structures that are
functionally important (Fig. 2). The myc oncoproteins contain a leucine zipper
(LZ) motif that is responsible for dimerization (Penn et al., 1990).

Drosophila

hairy, E(spl) and the mammalian homologues (e.g., HES) contain an orange
domain, a Drosophila C-terminal binding protein (dCtBP) motif (PLSLV) and a
Groucho motif (WRPW). The orange domain mediates transcription repression
(Dawson et al., 1995).

PLSLV and WRPW motifs mediate the recruitment of

transcription corepressors dCtBP and Groucho, respectively (Poortinga et al.,
1998, Sewalt et al., 1999, Zhang et al., 1999). A group of the bHLH proteins
(e.g., AHR and ARNT) contains a PAS domain that is responsible for
dimerization between PAS proteins, xenobiotic binding and interaction with nonPAS proteins (Lindebro et al., 1995, Gradin et al., 1996). A conserved domain C
in E proteins is also required for in vivo dimerization (Goldfarb et al., 1998).
bHLH

I

MyoD

bHLH

I

myc

I
II

Leucine zipper

Orange

bHLH

II

I

HES

I
c

E47

I

11

Groucho

111

PAS

bHLH
ARNT

dCtBP

II
bHLH

1111

I

Figure 2. Functional domains of bHLH proteins
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2. Classification of bHLH proteins
bHLH proteins are widely distributed in mammalian species, Drosophila, yeast
and plants. More than 250 bHLH proteins have been identified in mammals and
this number is increasingly expanding. Three systems based on different criteria
are currently used for the classification of these proteins. Each of these will be
discussed individually.

2. 1 Based on tissue distribution and dimerization

In this classification system, bHLH proteins in mammals are grouped into two
classes based on their expression pattern (Table 1). Class I, also known as Eprotein family, consists of bHLH proteins encoded by E2A, HEB and E2-2 genes
(Little et al., 1998).

E2A encodes E12 and E47, which are produced by

alternative splicing (Sun et al., 1991 ).

Class I proteins are ubiquitously

expressed and capable of forming transcriptionally active homo and/or
heterodimers.

Class II proteins display a tissue- or cell-restricted expression

pattern. For example, myogenic bHLH proteins (e.g., MyoD) present specifically
in muscle cell lineage while neurogenic bHLH proteins (e.g., NeuroD) present
mostly in neural system. Class II proteins can exist as homodimers, but the
active form is predominantly the heterodimers formed with class I proteins (Murre
etal., 1994, Little et al., 1998).
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Table 1. Classification based on tissue distribution and dimerization

Class

Example

Tissue distribution

Homodimer Heterodimer

Universal

Yes

Yes

No activity

Yes

E12, E47, HEB,
E2A
II

MyoD and NeuroD Restricted

2. 2 Based on structural domains

In this classification system, bHLH proteins are grouped into three classes based
on their structural domains (Table 2). Class I includes bHLH proteins (e.g., E47
and MyoD) that have a basic region adjacent to the N-terminus of the HLH
domain. Class II includes bHLHZ proteins (e.g., myc and Max) that contain an
additional LZ dimerization domain immediately C-terminal to the bHLH domain.
Class Ill includes HLH proteins that lack the DNA-binding domain due to the loss
of the basic region (e.g., Id).

These proteins act as negative regulators by

effectively forming inactive, non-DNA-binding heterodimers with other bHLH
proteins.

Although mammalian homologues of E(spl) such as HES have an

intact basic region, they also belong to this class because there is a proline
residue in their basic region, leading to a preference for an N-box instead of an
E-box site. The binding to the N-box results in transcription repression.
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Table 2. Classification based on structural features

Class

Family

I, bHLH proteins

Ubiquitous

E12/E47, HEB

Neurogenic

NueroD, MATH and Mash

Myogenic

MyoD, Myogenin, Myf5, MRF4

Haemato- poeitic

Ly1, Ly2, Tal1, Tal2, Hen1 and Hen2

Others

Arnt1, Arnt2 and Ah receptor

Proteins

II, bHLHZ proteins Myc

Ill, HLH proteins

c-Myc, N-Myc, L-Myc and v-Myc

Max

Max

Mad

Mad1, Mxi1, Mad3 and Mad4

AP4

AP4

USF

USF1 and USF2

lg enhancer binding

TFE3, TFEB, TFEC

Mammalian

Hes1, Hes2, Hes3, Hes4 and Hes5

homologues of (E(spl))
Id 1, ld2, ld3, and ld4

Id

2.3 Based on evolutionary relationship
This classification system was recommended recently based on the evolutionary
relationship among bHLH proteins (Atchley et al., 1997). In this classification, the
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phylogenetic analysis of amino acid sequences is used to describe the patterns
of evolutionary change within the motif and define the evolutionary lineages.
These evolutionary lineages are well-known functional groups of proteins that
can be further arranged into five classes based on the DNA binding (E-box), the
amino acid patterns in the basic region, and the presence or absence of a LZ
(Table 3).

The hypothesized ancestral amino acid sequence for the bHLH

transcription family is given together with the ancestral sequences of the
subclasses.

Table 3 Classification of bHLH proteins based on evolutionary relationship

Class

Protein

E-box

LZ

aa pattern in basic region

A

E12, MyoD, NeuroD

CAGCTG

No

5-8-13 (xRx)

B

Myc, ARNT, HES

CACGTG

Yes/No

5-8-13 (BxR)

c

sim

CACGTG

No

Not consistent

D

Id

No

No

No basic region

?

AP-4

CAGCTG

Yes

5-8-13 (xKx)

Note: aa, amino acid; 5-8-13, aa position; x, any aa; R, Arginine;
B, any basic aa; K, lysine.
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3. Transcription regulation of bHLH proteins
3. 1 Dimerization

bHLH proteins act as transcription modulators, and the dimerization is the
prerequisite for their function. For some bHLH proteins such as the ubiquitously
expressed E protein family (e.g., E12, E47), the active forms are either homo- or
heterodimers. Other bHLH proteins such as the myogenic MyoD family can exist
as homodimers, but the active dimers are the heterodimers. Consistent with this
finding, the antisense inhibition on E12 expression blocks the muscle-specific
gene expression induced by MyoD (French et al., 1991 ). bHLH proteins exhibit
different biological functions by heterodimerizing with different partners.

For

example, heterodimerization of Da with members of the Achaete-Scute class
leads to the formation of neuronal precursors (Cabrera et al., 1991 ).

On the

other hand, heterodimerization of Da with Atonal protein leads to the formation of
different, nonoverlapping sense organs and photoreceptors (Jarman et al., 1994).

3. 2 DNA binding

After dimerization, bHLH proteins usually bind to the cis-acting DNA elements
present in the target genes, resulting in the change of the gene expression.
These DNA elements contain core sequences CANNTG or CACNAG. CANNTG,
commonly known as the E-box, was first identified in the immunoglobulin heavychain (lgH) intronic enhancer and has been found in a large number of
pancreatic-, lymphoid-, and muscle-specific promoter and enhancer elements
(Little et al., 1998). CACNAG, commonly referred to as N-box, is present in the
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promoter of genes such as HES gene. Most bHLH proteins (e.g., MyoD, E12)
bind as dimers to E-box (Hsu et al, 1994), while some bHLH proteins (e.g., Hairy
and HES) prefer to binding to the N-box (Dawson et al., 1995). The binding
preference is specified by the sequence in the basic region of bHLH proteins.
Generally, the praline-containing basic region has a higher affinity toward the Nbox, whereas the basic region without a praline preferentially recognizes the Ebox. Some bHLH heterodimers recognize different core DNA sequences rather
than E- or N-box. For example, the AHR-ARNT complex usually binds to the
dioxin response element TNGCGTG (Bacsi et al., 1995).

3. 3 Transcriptional regulation

Binding to specific DNA elements by bHLH proteins leads to transcriptional
activation or repression.

MyoD and its related myogenic bHLH proteins, for

example, bind to the E-box and activate transcription of myogenic genes
(Weintraub et al., 1991 ).

Drosophila Hairy and its related protein E(spl) and

HES, however, bind to the N-box and inhibit the transcription of neurogenic
genes (Dawson et al., 1995). This transcription repression process is outlined in
Fig. 3.

The N-box binding of transcription repressive proteins such as Hairy

results in an orange domain-mediated repression on the E-box binding proteins
such as Da/Scute. This binding also leads to a recruitment of Groucho, which is
a transcription corepressor. Other than the N-box binding, Drosophila Hairy and
its related proteins have been shown to form non-functional heterodimers with Ebox binding bHLH transactivation proteins (Sasai et al., 1992).
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Therefore,

transcriptional repression of bHLH proteins is achieved in two distinct manners,
binding to the N-box and/or titrating other bHLH proteins.

othcn
activator•

------

x
Figure 3. Model for N-box binding mediated transcription repression
(Dawson et al. , 1995)

Both transcription activation and repression mediated by bHLH proteins are
essential for organ development.
For

Lack of either mechanisms results in

developmental

defects.

example,

Mash1

promotes

the

neuronal

differentiation.

The absence of Mash1 in mice results in death at birth

accompanied by the loss of olfactory and autonomic neurons (Guillemot et al.,
1993).

HES proteins, however, suppress the neuronal differentiation.

The

absence of HES proteins (e.g ., HES1) accelerates neuronal differentiation,
resulting in severe defects such as anencephaly and eye anomalies (Ishibashi et
al. , 1995).
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4. Other features of bHLH proteins
In addition to the characteristics described above, bHLH proteins also have other
important properties in the organ developmental processes.

Some bHLH

proteins compensate functionally for each other and are subjected to auto- and
cross-regulation. For example: 1. Myf5, a myogenic bHLH protein, was initially
found indispensable for normal rib cage development.

In a later experiment,

however, the insertion of the myogenin gene, a homologue of myf5, into the myf5
locus (simultaneously disrupting myf5 function) was found to give rise to mice
with a normal rib cage (Wang, et al., 1996). 2. In vertebrate myogenesis, MyoD,
Myf5 and myogenin all up-regulate their own expression. They are also able to
regulate the expression of others (Fig. 4 ). MyoD is required for the expression of
myogenin.

Myf5 induces MyoD, and Id is inactivated by MyoD.

A similar

complex network also occurs in bHLH proteins involved in neurogenesis and sex
determination.

V crtcbutc
myogcncsis ~

El2 or E47

T

fMvyogenin
~

muscle

) !----.,._ specific

MRF4

genes

determined
myoblast

differentiated
myocytc

Id proteins
?Hes proteins
precursor

Figure 4. Networks of bHLH proteins involved in vertebrate myogenesis
(Little et al., 1998)
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II. Significance of bHLH Proteins in Oncogenesis

The bHLH proteins play important roles in the control of cellular proliferation and
differentiation in various lineages, from invertebrates to mammals. An imbalance
between the cell proliferation and differentiation caused by bHLH proteins may
have

oncogenic

significance.

Generally,

proliferation-promoting

action

oncogenic, while differentiation-promoting action is tumor-suppressing.

is

Myc

proteins, for example, are known to promote cell proliferation and inhibit
differentiation (Penn et al., 1990, Chin et al., 1995). Several members of the myc
family in cooperation with an activated ras oncogene have transformed primary
rat embryonic cells in culture (Land et al., 1986). Transgenic mice with enforced
c-myc expression also exhibit a significantly higher incidence of malignancy than
control mice (Davis et al., 1993).

E proteins, on the other hand, promote cell differentiation. The E2A-null mice
(the absence of E2A protein) develop T-cell tumors (Yan et al., 1997). Tal1, a
putative oncogene originally identified through its involvement in T-cell acute
lymphoblastic leukemia {T-ALL), does not form homodimers but dimerize tightly
with E proteins. Such heterodimers confer little transactivation activity (Steven et
al., 1998). Sequestration of E proteins by Tal1 oncoprotein likely results in cell
de-differentiation and induces oncogenic pathogenesis.
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The oncogenic mechanisms by bHLH proteins remain to be established. The
deregulation of gene expression by these proteins plays a major role in tumor
formation. For example, the p53 tumor suppressor gene contains an essential
CACGTG motif within the promoter region. The ectopic c-myc can specifically
bind to this motif and activate the expression of the mutant p53, leading to
oncogenic transformation (Popescu et al., 1998). Other than the gene regulation,
a protein-protein interaction is also found responsible for the oncogenesis of
some bHLH proteins. For example, in the presence of overexpressed LM01, the
enforced expression of an amino-terminal truncated Tal1, which lacks the
transactivation domain, leads to aggressive T-cell malignancies in transgenic
mice (Aplan et al., 1993). In this case, Tal1 is not acting by transactivation of the
target genes, but acting through a protein-protein interaction.

Ill. Statement of Purpose

A full-length cDNA was recently isolated in our lab from a human liver library by a
gene trapping method. The sequence alignment reveals that this cDNA encodes
a protein highly similar to bHLH proteins such as human DEC1 (-92%), and rat
SHARP (-80%) and mouse strate 8, particularly in the region encoding functional
structures such as bHLH domain (Fig. 5). DEC1 is a Bt2cAMP inducible bHLH
protein that may function as a transcription regulator in chondrogenesis (Shen et
al., 1997).

SHARP proteins are mammalian E(spl) and hairy-related bHLH

proteins that play essential roles in neurogenesis (Rossner et al., 1997).
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<

basic

><

helix 1

><

loop

><

helix 2

>

CCAF

ETYKLAAPAHR- -EKEERDRINECIAQLKDLLPEHLKLTTLGHLEKAWLELTl KHVKALT

DEC1

ETYKL - - P- HRLIEKKRRDRINECIAQLKDLLPEHLKLTTLGHLEKAWLELTLKHVKALT

SHARP ETYKL- - P- HRLIEKKRRDRINECIAQLKDLLPEHLKLTTLGHLEKAWLELTLKHVKALT

Figure 5. Comparison of CCAF bHLH domain with other bHLH proteins

Based on the Kozak rule, this cDNA encodes a 415 amino acid protein termed
colon cancer-associated factor (CCAF), from the first starting AUG codon, which
is harbored by a Kozak favorable sequence. The purpose of this thesis is to
determine that the translation is indeed started from the first AUG codon
and to establish the molecular weight of CCAF. CCAF was in vitro translated
with TNT reticulocyte lysate. The molecular weight of the synthesized CCAF was
determined via SDS-polyacrylamide gel electrophoresis (SOS-PAGE) followed by
autoradiography. In order to further determine whether CCAF undergoes
posttranslational modifications, in vivo COS? cell transient transfection was
performed. The CCAF cDNA-transfected cell lysates were subjected to SOSPAGE and then immunochemically detected by an antibody, which was raised
against a peptide derived from CCAF and purified via affinity chromatography.
This antibody was also used to determine the cellular localization of CCAF.

bHLH proteins are known to play important roles in the control of cellular
proliferation and differentiation. The experiments in this thesis were designed
to determine the expression of CCAF in different cell growth states. OLD
cells derived from colon carcinomas were seeded at different densities, inducing
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different cell growth states. The CCAF expression in each state was detected by
the antibody prepared against CCAF. OLD cells were also seeded at a certain
density, and after reaching confluence, cells were maintained in the same
medium or changed to 0.25% medium for 4 additional days. The expression of
CCAF was detected at each day point by the same antibody.

The deregulated or ectopic expression of some bHLH proteins (e.g., myc and
Tal1) is known closely related to the oncogenic pathogenesis. The experiments
in this thesis were designed to determine the expression of CCAF in human
carcinomas and the normal nearby tissues.

Northern blot probed with

radioactive-labeled CCAF cDNA was performed to detect the CCAF gene
expression in cancer and nearby normal tissues.

The same antibody against

CCAF was also used to detect the CCAF protein expression in these tissues.

In addition to the bHLH domain, CCAF contains an orange domain and a
modified dCtBP motif (PLSLV), which are present in the transcription repressive
bHLH proteins such as Drosophila Hairy and mammalian HES (Fig. 6).

The

purpose of the studies in this thesis was to test the hypothesis that CCAF
is a transcription modulator. To determine the activity of CCAF in transcription
regulation, transient cotransfection assays were conducted with an E-box
reporter in COS? cells.

The transcriptional modulation activity of CCAF was
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determined by measuring the E-box mediated enzyme expression with a dualluciferase assay.

bHLH
CCAF

I

Orange

I I

bHLH
Hairy

I

dCtBP

11
Orange

dCtBP

I I

11

Groucho

111

Figure 6. Function domains of CCAF and bHLH repression protein

Overall, the objectives of this thesis are to establish the molecular mass of this
protein and to test the hypothesis that CCAF is a transcriptional modulator
involving the regulation of cell cycle events. The results in this thesis will provide
a fundamental basis for further characterization of CCAF such as the proteinprotein interaction and transactivation activity, and therefore expand our
understanding of the physiological and pathological significance of bHLH
proteins.
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Table 4. Abbreviation of bHLH proteins

Ah

aryl hydrocarbon

AP4

activator protein 4

Arnt

Ah receptor nuclear translocation protein

Da

Daughterless protein (Drosophila)

E-box

Ephrussi box, consensus sequence CANNTG

E(spl)

Enhancer of split protein (Drosophila)

HEB

Hela Ebox binding factor

HES

Hairy- and Enhancer of split-related mammalian proteins

Id

inhibitor of differentiation protein

Hen

Helix-loop-helix encoded in neuroblastoma protein

Ly1

lymphoid leukaemia protein

Mad

Max-associated dimer protein

Mash

mammalian Achaete-Scute homologue protein

Max

Myc-associated x protein

Maxi1

Max interactor 1 protein

MRF4

muscle regulatory factor 1

Myf

myogenic factor

MyoD

myogenic determination factor

N-box

consensus sequence CACNAG

Tai

T cell acute leukemia protein

TFE3

transcription factor E3 binding

TFEB

transcription factor enhancer binding

TFEC

transcription factor C

USF

upstream stimulatory factor

19

MATERIALS AND METHODS

Plasmid construction
E4 7 and E-box-luciferase reporter plasmids were kindly provided by Dr. Jinming
Chiu (Ohio State University, Ohio). CCAF cDNA was cloned from human liver
cDNA library in our lab with a Gene Trapping kit (GIBCO BRL, Grand Island,
NY). The plasmid DNA of CCAF was isolated with a QIAprep Spin Minip.rep kit
(QIAGEN Inc., Valencia, CA).

The partial sequencing was determined with a

Sequi Therm EXCEL II DNA Sequencing Kit (Epicentre Technologies, Madison,
WI) by T? or SP6 primer. The entire sequence was characterized by Genemed
Synthesis Inc. (South San Franciscan, CA).

Transformation and endotoxin-free plasmid extraction
The plasmid was incubated with JM109 bacteria for 20 min on ice, followed by a
heat-shock for 45-50 sec at exactly 42°C in a water bath.

After 1.5 hr of

incubation in SOC medium at 37°C with shaking, the transformed bacteria grew
overnight at 37°C in 1.5 % agar plates (100 µg/ml ampicilin). Positive colonies
with E4 7 or E-box-luciferase cDNA insertion were identified with restriction
enzymes and analyzed by 1% agarose gel electrophoresis.

CCAF, E4 7 and E-box-luciferase reporter plasmids for in vitro translation and in
vivo transfection were isolated with an EndoFree Plasmid Maxi kit (QIAGEN,
VALENCIA, CA). The individual colonies were incubated in 2-5 ml selective LB
medium (100 µg/ml ampicilin) at 37°C for 8 hr with vigorous shaking (-300 rpm).
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They were then diluted at 1: 1000 into 100 ml selective LB medium and grew
under the same conditions for 12-16 hr.

Bacteria were harvested by

centrifugation for 10 min at 4 °C, 6000 rpm (JOUAN, Winchester, VA), and
plasmid DNAs were isolated according to the instruction of the manufacturer.
The concentration of plasmid DNA was determined by measuring optical density
(OD) with an UV spectrometer at a wavelength of 260 nm (1 OD = 50 µg/ml
plasmid DNA).

In vitro translation
CCAF was in vitro synthesized via a TNT-coupled reticulocyte lysate system
(PROMEGA, Madison, WI) following the instruction by the manufacturer. Briefly,
CCAF plasmids (0.5 µg) were added to 25 µI of reaction mixture containing
reticulocyte

lysate,

amino

acid

methionine and SP6 polymerase.

mixture

without

methionine,
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S-labeled

After 60 min of incubation at 30°C, the

reaction mixture was chased by adding 625 µM unlabelled methionine (0.5 µI) for
30 min.

To determine the molecular weight of the synthesized CCAF, the

mixture (5 µI) was denatured in 20 µI of 1X SOS-PAGE sample buffer (31.25 mM
Tris-HCI at pH6.8, 5% glycerol, 0.025% bromophenol blue and 2.5% 2mercaptoethanol) at 80°C for 5 min and size-separated via SOS-PAGE. The gel
was washed with solution A (50% methanol and 10% acetic acid) for 30 min and
then solution B (7% methanol, 7% acetic acid and 1% glycerol) for 5 min. CCAF
was detected by exposing the vacuum-dried gel to an X-ray film.
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Cell culture
The COS? cell line was provided by Dr. Hixon (Rhode Island Hospital, RI). The
OLD colon cancer cell line was provided by Dr. Chichester (University of Rhode
Island, RI).

Unless otherwise indicted, all the reagents for cell culture were

purchased from GIBCOL BRL (Grand Island, NY). COS? cells grow in
Dulbecco's Modified Eagle's medium (DMEM) supplemented with 10% fetal calf
serum (FCS), 1 mM pyruvate, 1x nonessential amino acids, 2 mM L-glutamine
and 50 µg/ml gentamicin. OLD cells grow in RPMI 1640 medium supplemented
with 10% FCS, 2 mM L-glutamine, 1 x nonessential amino acids and 25 µg/ml
gentamicin. Both cell lines were maintained at 37°C, 5% C02 , 95% 0 2 and 100%
humidity.

After reaching confluence, cells were split by digestion with 0.5%

trypsine for 4 to 5 min at 37°C. The number of cells was counted via a
hemotocytemeter under a reverse-controversial microscopy after 0.4% typan
blue staining.

Transient transfection
CCAF endotoxin-free plasmids were transiently transfected into COS? cells via
lipofectamine, a cationic lipid as described by the manufacturer (Gibco BRL
Gaithersburg, MD).

COS? cells were seeded in 12-well plates (CORNING,

Corning, NY) in RPMI 1640 medium supplemented with 10% FCS at a density of
1x105 cells per well.

On day 2, cells achieved 60-80% confluence.

Prior to

transfection, plasmid DNA (0.2 or 0.4 µg) was mixed with lipofectamine (2 µI) in
80 µI of transfection DMEM (without FCS and gentamicin) at room temperature
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for 45 min, and then diluted to 320 ml with the same medium.

Cells were

exposed to the transfection mixture at room temperature for 4 to 5 hr, and
switched to normal DMEM.

The transfected cells were incubated for an

additional 48 hr and harvested in lysis buffer (1 % SOS in Tris-HCI buffer, pH 6.8,
150 µI per well). Protein concentration of cell lysate was assayed with a BCA
micro protein assay kit (PIERCE, Rockford, IL) at a wavelength of 570 nm via a
MRX microplate reader (DYNEX, Chantily, VA). A dilution of sample at 1:40 was
usually required before performing the protein assay.

Cotransfection and dual luciferase assay
To determine the activity of CCAF on gene transcription, E-box-luciferase
reporter plasmids (160 ng) were cotransfected with CCAF plasmids (100 ng) to
COS? cells in the presence of lipofectamine following the same procedure as
described above. E47 plasmids (100 ng) were transfected as a positive control.
pRL-TK plasmids (32 ng, Promega, Madison, WI) encoding Renilla luciferase
served as a background control.

Transfected cells were incubated for 48 hr,

rinsed with sodium phosphate buffer twice and lysed in 250 µI of passive lysis
buffer at room temperature for 15 min on a rocking platform.

The reporter

enzyme activities were determined with a Dual-luciferase Reporter Assay System
via a TD-20/20 luminometer (Promega, Maison, WI). The assay program was
set up to a 2-second delay and a 10-second integration.

This assay system

contains two substrates, which give rise to two kinds of luminescence signals.
The Firefly luminescence signal , which represented the reporter gene activity,
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was initiated by mixing cell lysate (20 µI) with substrate Luciferase Assay
Reagent II (LARll, 100 µI). The Renil/a luminescence signal, which represented
the background luciferase activity, was detected by sequentially adding Stop &
Glu reagent (100 µI) to the same mixture.

The induction of reporter enzyme

activity was designated as the ratio of Firefly luminescence signal over the
Renilla luminescence signal.

In this experiment, each group was tested in

triplicate and repeated once.

SOS-Polyacrylamide gel electrophoresis
SOS-PAGE was conducted with Minimum Gel Apparatus (BioRad, Hercules,
CA). The gel contained two parts: 4% polyacrylamide staking gel (0.25 M TrisHCI, pH6.8, 1% SOS) on the top and 7.5% polyacrylamide separating gel (0.375
M Tris-HCI, pH8.8, 1% SOS) at the bottom. Cell lysate containing 15 µg protein
was denatured in equal volume of 2 x SOS-PAGE sample buffer (62.5 mM TrisHCI at pH 6.8, 2% SOS, 10% glycerol, 0.025% bromphenol blue, 5% 2mercptoethanol) at 95°C for 5 min and centrifuged at 11,000 rpm for 10 min. The
supernatant was separated in the stacking gel at 43 V, 16 mA for about 30 min
and in the separating gel at 120 V, 26 mA for about 1.5 hr.

Coomassie blue assay
Transfected cell lysate was subjected to SOS-PAGE as described previously.
The gel was stained for half an hour with 0.1 % Coomassie blue R-250 in a
fixative solution (40% MeOH, 10% HOAc), destained with 40% MeOH/10%

24

HOAc (1 to 3 hr) to remove the background and then vacuum-dried on a gel
drier. The expression pattern of total proteins in transfected COS? cells was
visualized by Coomassie blue staining.

Antibody purification
A polyclonal antibody specific to the peptide (CSQALKPIPPLNLETKD) derived
from C-terminus of CCAF was raised in New Zealand White rabbits in our lab.
To diminish the nonspecific binding, the antibody was purified by immunoaffinity
chromatography. This was conducted as described by Harlow and Lane (Harlow
et al, 1988). First, the peptide (1 mg) was covalently coupled to 2 ml of SulfoLink
gel (PIERCE, Rockford, IL) via incubation at room temperature for 30 min in a
PD-10 column (Pharmacia Biotech, Sweden). 50 mM cysteine (2 ml) was then
added to block the nonspecific binding sites. Prior to applying the antiserum, this
antigen-coupled gel column was sequentially pretreated with 20 ml of Tris
(pH7.5), 20 ml of 100 mM glycine (pH 2.5) and 20 ml of 100 mM triethylamine
(pH11.5, fresh). The antiserum (5 ml) was 1:1 diluted with 10 mM Tris (pH7.5)
and repetitively applied to the column three times to ensure the complete binding.
The column was washed with 40 ml of 10 mM Tris (pH7.5) followed by 40 ml of
500 mM NaCl in 10 mM Tris (pH7.5). The antigen specific antibody was then
eluted from the column with 20 ml of 100 mM glycine (pH2.5), and collected in a
tube containing 5 ml of 1M Tris-HCI (pH 8.0). The elution was dialyzed in a tu bin
against PBS (containing 0.02% sodium azide) at 4°C overnight with stirring, and
then aliquoted and stored at -20°C.
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Western immunoblotting
The transfected cell lysate was subjected to SOS-PAGE as described previously.
For immunoblot analysis, the separated proteins were transferred to a
nitrocellulose membrane by electroblotting for 1 hr 20 min at 36 V, 150 mA in
transfer buffer (25 mM Tris, 190 mM glycine, and 20% methanol).

The

membrane was then blocked in 5% non-fat dry milk in TBST (10 mM Tris 8.0,
150 mM NaCl, 0.05% Tween 20) for half an hour, and probed by the purified
antibody at 1: 100 dilution for 1 hr. The membrane was then washed three times
(5-10 min/each) with TBST, and incubated with an alkaline phosphataseconjugated anti-rabbit lgG at 1:5000 dilution for at least 0.5 hr.

lmmunoblots

were developed by color precipitation catalyzed by phosphatase in the presence
of chromogenic substrates, 5-bromo-4-chloro-3-indolyl phosphate (BCIP) and
Nitro blue tetrazolium (NBT) in alkline phosphatase buffer (0.1 M Tris, o.1 M NaCl,
and 5mM MgCl2, pH9.5).

CCAF expression at different cell growth states
In this experiment, different cell growth states were induced by three individual
methods: ( 1) OLD colon cancer cells were seeded in 12-well plates at various
densities (1-8 x 105 cells per well) in RPMI 1640 with 10% FCS. The medium
was changed daily after seeding. Cells were harvested 3 days after seeding. (2)
OLD cells were seeded in 12-well plates at a cell density of 2.5x10 5 per well in
RPMI 1640 medium with 10% FCS. After achieving confluence (about 3 days),
cells were maintained in the same medium for additional 4 days.
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Cells were

harvested at each of the 7-day points. (3) OLD cells were treated in the same
way as (2) except maintaining confluent cells in 0.25% serum for an additional 4
days.

All the cells were harvested in the same lysis buffer.

Protein

concentration in cell lysate was determined with a SCA micro protein assay kit,
and each sample containing 15 µg protein was immunoblotted with the antibody
against CCAF as described previously.

CCAF gene expression in human colon carcinomas
Total RNAs from human colon cancer and normal tissues were isolated with a
TRI REAGENT kit following the instruction of the manufacturer (Sigma, St. Louis,
MO).

The RNA concentration was determined via UV absorbance at 260 nm,

with 1 OD unit equal to 40 µg/ml RNA. Samples (20 µg RNA) was fractionated
via electrophoresis in a 1.2% agarose gel containing 2.2 M formaldehyde, and
electroblotted to a Nytran nylon membrane (Schleicher & Schuell, Keene, NH)
with a vacuum-blotting system (Pharmacia, Piscataway, NJ).
was hybridized with a
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The membrane

P-labelled CCAF cDNA probe (-2 x 106 cpm) in 5 ml of

hybridization buffer (250 mM sodium phosphate buffer, pH7.2, 1 mM EDTA, 7%
SOS and 0.01 % bovine serum albumin) overnight at 68°C in a rotating oven
(Robbins Scientific, Clayview, CA).

After hybridization, the membrane was

washed at 68°C for 1 hr in hybridization buffer (2 x 30 min) and for 1 hr in 40 mM
sodium phosphate buffer (pH 7.2, 1 mM EDTA and 1% SOS) (2 x 30 min). An Xray film (Sigma Chemical Co, St, Louis, MO) was exposed to the membrane with
intensifying screen until an appropriate autoradiography was obtained.
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CCAF protein expression in human colon carcinomas
To compare the CCAF protein expression in human colon cancer to normal
tissues, homogenates of each sample (15 µg protein), which were provided by
Dr. Nancy Thomas (Rhode Island Hospital, RI), were size-separated by SDSPAGE and immunodetected with the antibody against CCAF as described earlier.

Determination of CCAF localization
OLD cells were cultured in 12-well plates in RPMI medium with 10% FCS. When
reaching confluence, cells were rinsed twice with ice-cold PBS (1 ml/well), and
detached by a rubber policeman. The cells were collected and centrifuged for 5
min at 2000 rpm, 4°C. The cell pellet was mixed with 100 µI of NP-40 lysis buffer
A (10 mM Tris, pH7.4, 10 mM NaCl, 3 mM MgCl2 and 0.5% NP-40) on ice for 5
min followed by centrifugation at 1000rpm, 4°C for 5 min.

The supernatant

containing cytosol proteins were stored in 0.5 ml plastic tubes while the nuclear
proteins in the pellet were redissolved in 70 µI of 1% SDS lysis buffer. All the
samples

prepared

above

were

separated

via

SOS-PAGE

followed

immunoblotting with antibody against CCSF as described previously.
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RESULTS

CCAF is a 52-KDa protein.
To establish the molecular weight, CCAF was in vitro translated with TNT
reticulocyte lysate and analyzed by autoradiography.

Addition of the CCAF

cDNA to the reaction mixture yielded a single product with a molecular weight of
52-kDa (Fig. 7). This mass is consistent with the estimated weight. In order to
determine whether CCAF undergoes posttranslational modifications, the CCAF
cDNA-transfected COS? cell lysates were size-separated via SOS-PAGE and
analyzed by Coomassie blue assay and Western immunoblotting, respectively.
As determined by Coomassie blue assay, an extra band with a molecular weight
of 52-kDa was detected in the CCAF-transfected cells, and the level of the
protein

expression

increased with the

increase of the

CCAF

plasmid

concentration (Fig. 8, lane 2 and 3). An antibody was raised against a peptide
derived from CCAF and subjected to affinity chromatography.

This antibody

detected the 52-kDa protein in the CCAF cDNA-transfected cells but not in the
control cells (Fig. 9). Thus, three independent assays all demonstrated that the
isolated full-length cDNA encodes a protein with a molecular weight of 52-kDa.

CCAF expression is related to the cell growth states.
To determine the CCAF expression in different cell growth states, OLD colon
cancer cells were seeded at different densities, and the cell lysates were
fractionated via SOS-PAGE and then analyzed by western immunoblotting. As
shown in Fig. 10, the antibody against CCAF detected a 52-kDa protein in OLD
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cells at all seeding densities. But the expression of this protein increased with
the plating densities. The level of this protein in the cells that are seeded at high
density was -3 to 5-fold higher (lane 3, 4 and 5) than that in the cells that are
seeded at low density (lane 1 and 2).

To further confirm this expression pattern, OLD cells were seeded at a certain
density, and after reaching confluence, cells were maintained in the same
medium or changed to 0.25% medium for 4 additional days. The expression of
CCAF was detected at each day point by the same antibody against CCAF. As
shown in Fig. 11, the CCAF expression was hardly detectable before cell
reaching confluence (lane1 and 2), while after confluence, the level of CCAF
protein increased about 3-5 folds (lane 3-6).

The level of CCAF expression was

also positively related to the starvation days (Fig. 12).

CCAF is abundantly expressed in human colon carcinomas but not in the nearby
normal tissues.
Northern blot with the radiolabeled full-length cDNA screened the CCAF mRNA
expression in various human carcinomas.

Except kidney and ovary cancer,

CCAF gene expression was significantly high in some carcinomas such as lung
and breast when compared to that in normal tissues (Data not shown).
Particularly, without exception, this cDNA detected abundant expression of
CCAF in 5 individual colon cancer cases but not in the nearby normal tissues
(Fig. 13).

The same results were also obtained by using immunoblotting to
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detect the CCAF protein expression in colon carcinomas. As shown in Fig. 14,
the antibody specific to CCAF recognized a strong band with a molecular weight
of 52-kDa in samples from 3 individual colon cancer patients (Lane 3, 4 and 5).
In contrast, no bands were detected by the same antibody in normal nearby
tissues (Lane 6 and 7).

CCAF is localized in cell nucleus.
DLD cytosol proteins were separated from nuclear proteins, and both were
subjected to Western immunoblotting analysis. As shown in Fig. 15, the antibody
against CCAF recognized a protein with a molecular weight of 52-kDa in nucleus
but not in cytosol, suggesting that the CCAF protein is a nuclear protein.

CCAF inhibits the transactivation activity of E4 7 on an E-box reporter.
To test the activity of CCAF on the gene regulation, CCAF plasmids were
cotransfected with an E-box luciferase reporter and the induction of reporter
enzyme was determined via a dual-luciferase assay system. As shown in Fig.
16, E47, a bHLH protein that is known to transactivate E-box reporter, promoted
a 380-fold increase of luciferase activity.

In contrast, CCAF caused little

activation on luciferase expression by itself, but partially antagonized by 30% the
enzyme induction conferred by E47.
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Figure 7. In vitro translation

CCAF was synthesized in vitro via a TNT-coupled reticulocyte lysate system.
CCAF plasmids (0.5 µg) were added to 25 µI of reaction mixture containing
reticulocyte

lysate,

amino

acid

methionine and SP6 polymerase.

mixture

without

methionine,

35

S-labeled

After 60 min of incubation at 30°C, the

reaction mixture was chased by adding 625 µM unlabelled methionine (0.5 µI) for
30 min. To determine the molecular of synthesized CCAF, the mixture (5 µI) was
denatured in 20 µI of 1X SOS-PAGE sample buffer (31.25 mM Tris-HCI at pH6.8,
5% glycerol, 0.025% bromophenol blue and 2.5% 2-mercaptoethanol) at 80°C for
5 min and size-separated via SOS-PAGE. The gel was washed with solution A
(50% methanol and 10% acetic acid) for 30 min and then solution B (7%
methanol, 7% acetic acid and 1% glycerol) for 5 min. The synthesized CCAF
was detected by autoradiography.
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Figure 8. Coomassie Blue Assay

Transfected cell lysate was subjected to SOS-PAGE. The gel was stained for
half an hour with 0.1% Coomassie blue R-250 in a fixative solution (40% MeOH,
10% HOAc), destained with 40% MeOH/10% HOAc (1 to 3 hr) to remove the
background and vacuum-dried on a gel drier.
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Figure 9. Western immunoblotting
The transfected cell lysate was subjected to SOS-PAGE. The separated proteins
were transferred to a nitrocellulose membrane by electroblotting for 1 hr 20 min
at 36 V, 150 mA in transfer buffer (25 mM Tris, 190 mM glycine, and 20%
methanol). The membrane was then blocked in 5% non-fat dry milk in TBST ( 10
mM Tris 8.0, 150 mM NaCl, 0.05% Tween 20) for half an hour, and probed by the
purified antibody at 1:100 dilution for 1 hr. The membrane was washed three
times (5-10 min/each) with TBST, and incubated with an alkaline phosphataseconjugated anti-rabbit lgG at 1:5000 dilution for at least 0.5 hr.

lmmunoblots

were developed by color precipitation catalyzed by phosphatase in the presence
of chromogenic substrates, 5-bromo-4-chloro-3-indolyl phosphate (BCIP) and
Nitro blue tetrazolium (NBT) in alkline phosphatase buffer (0.1 M Tris, o.1 M NaCl,
and 5mM MgCl 2 , pH9.5).
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Figure 10. CCAF expression at different cell densities
OLD colon cancer cells were seeded in 12-well plates at various densities ( 1-8 x
105 cells per well) in RPMI 1640 with 10% FCS. The medium was changed
everyday after seeding . On days 3 after seeding , cells were harvested in lysis
buffer. Each sample containing 15 µg protein was analyzed with antibody
against CCAF. CCAF-transfected COS? cell lysate is also included in this
experiment.
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Figure 11. CCAF expression at different cell growth states
(without changing medium)
OLD cells were seeded in 12-well plates at a cell density of 2.5x10 5 per well in
RPMI 1640 medium with 10% FCS. After achieving confluence (about 3 days),
cells were maintained in the same media for additional 4 days.

At each day

point, cells were harvested in lysis buffer. Each sample containing 15 µg protein
was analyzed with antibody against CCAF.
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Figure 12. CCAF expression at different cell growth states

(changing to 0.25% FCS)
OLD cells were seeded in 12-well plates at a cell density of 2.5x10 5 per well in
RPMI 1640 medium with 10% FCS. After achieving confluence (about 3 days),
cells were switched to medium containing 0.25% FCS for additional 4 days. At
each day point, cells were harvested in the lysis buffer. Each sample containing
15 µg protein was analyzed by immunoblotting. This figure compared the CCAF
expression between two days after starvation .
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Figure 13. CCAF gene expression in human colon carcinomas
Total RNAs from human colon cancer and normal tissues were isolated with a
TRI REAGENT kit. Samples (20 µg RNA) was fractionated via electrophoresis in
a 1.2% agarose gel containing 2.2 M formaldehyde, and blotted to a Nytran nylon
membrane with a vacuum-blotting system. The membrane was hybridized with a
32

P-labelled CCAF cONA probe (-2 x 106 cpm) in 5 ml of hybridization buffer

(250 mM sodium phosphate buffer, pH7.2, 1 mM EOTA, 7% SOS and 0.01%
bovine serum albumin) overnight at 68°C in a rotating oven. After hybridization,
the membrane was washed at 68°C for 1 hr in hybridization buffer (2 x 30min)
and for 1 hr in 40 mM sodium phosphate buffer (pH 7 .2, 1 mM EOTA and 1%
SOS) (2 x 30 min). CCAF gene expression was visualized by autoradiography.
The results shown in this figure were obtained from 5 individual patients.
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Figure 14. CCAF protein expression in human colon carcinomas
To compare the CCAF protein expression between human colon cancer and
normal tissues, homogenates of each sample (15 µg protein) were sizeseparated by SOS-PAGE and analyzed by immunoblotting.
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Figure 15. CCAF nuclear localization

OLD cells were cultured in 12-well plates in RPMI medium with 10% FCS. When
reaching confluence, cells were rinsed twice with ice-cold PBS (1 ml/well), and
detached by a rubber policeman. The cells were collected and centrifuged for 5
min at 2000 rpm, 4°C. Cell pellet was mixed with 100 µI of NP-40 lysis buffer A
(10 mM Tris, pH7.4, 10 mM NaCl, 3 mM MgCl2 and 0.5% NP-40) on ice for 5 min
followed by centrifugation at 1000rpm, 4°C for 5 min. The supernatant containing
cytosol proteins were stored in 0.5 ml plastic tubes while the nuclear proteins in
the pellet were redissolved in 70 µI of 1% SOS lysis buffer.

All the samples

prepared above were separated via SOS-PAGE and analyzed by immunoblotting
with antibody against CCAF.
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Figure 16. Cotransfection and dual luciferase assay

E-box-luciferase reporter plasmids (160 ng) was cotransfected with CCAF
plasmids ( 100 ng) into COS? cells in the presence of lipofectamine following the
same procedure as described in the Materials and Methods. E47 plasmids (100
ng) were transfected as a positive control. pRL-TK plasmids (32 ng) encoding
Renil/a luciferase served as a background control.

Transfected cells were

incubated for 48 hr, rinsed with sodium phosphate buffer twice and lysed in 250
µI of passive lysis buffer at room temperature for 15 min on a rocking platform.
The reporter enzyme activities were determined with a Dual-luciferase Reporter
Assay System via a TD-20/20 luminometer. The Firefly luminescence signal was
initiated by mixing cell lysate (20 µI) with substrate Luciferase Assay Reagent II
(LARll, 100 µI). The Renil/a luminescence signal was detected by sequentially
adding Stop & Glu reagent (100 µI) to the same mixture.

The induction of

reporter enzyme activity was expressed as the ratio of Firefly luminescence
signal over Renil/a luminescence signal.
tested in triplicate and repeated once.
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DISCUSSION
Basic helix-loop-helix (bHLH) proteins belong to a large family of transcription
factors that are known to play important roles in cell proliferation, differentiation
and oncogenesis.

These proteins are structurally featured by a bHLH motif,

which is responsible for protein dimerization and sequence-specific DNA binding
(e.g., E-box). Recently we isolated a cDNA from a human liver library by a gene
trapping method.

Sequence alignment indicates that this cDNA encodes a

putative bHLH protein termed CCAF. The objective of this thesis is to establish
the molecular mass of this protein and to test the hypothesis that CCAF is a
transcriptional modulator involving the regulation of cell cycle events.

CCAF is a 52-kDa protein with little posttranslational modifications.
Based on the Kozak rule, the largest protein encoded by the isolated cDNA is
415 amino acids long with a calculated molecular mass of 52-kDa.

One of the

studies described in this thesis is to determine the molecular weight of CCAF.
This is achieved by measuring the mass of CCAF translated in vitro and in CCAF
cDNA-transfected cells. In both methods, a protein with a molecular weight of
52-kDa is produced. The consistence with the calculated mass suggests that
CCAF undergoes little posttranslational modifications.

CCAF is a cell cycle regulator.
The expression of CCAF is detected in different cell growing states induced by
either contact inhibition or serum starvation. The proliferating cells express lower
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level of CCAF than the growing-arrest cells.

This differential expression is

closely related to the regulation of cell cycle. Myc proteins are highly expressed
in the proliferating cells but less in the differential cells, and these proteins are
known to promote the cell proliferation but inhibit the differentiation (Penn et al.,
1990, Chin et al., 1995). The low level of CCAF in the proliferating cells suggests
that CCAF is a cell cycle regulator, which has little proliferation-promoting activity
but plays an important role in the rescuing cells from death (anti-apoptotic).

CCAF has oncogenic significance.
The expression pattern of CCAF in different cell growing states is similar to the
oncoprotein junD, which is found to cooperate with ras oncogene in transforming
rat embryo fibroblast (Vandel L et al., 1996). This similarity suggests that CCAF
has oncogenic significance. Moreover, abundant CCAF is found in human colon
carcinomas but not in the nearby tissues. Ectopic and deregulated expression of
several bHLH proteins is related to oncogenesis. Tal1 and other closely related
bHLH proteins (Tal2 and LYL 1), are normally not expressed in T cells, but are
constitutively expressed in >60% of T-cell acute lymphoblastic leukemia (T-ALL)
(Alphan et al., 1992, Bash et al., 1995). In transgenic mice, overexpression of
TAL 1 gene in cooperation with a misexpressed LM01 protein induces aggressive
T-cell malignancies (Aplan et al., 1993).

It has been proposed that the progression of a tumor might not only be a function
of cell proliferation but also result from inappropriate suppression of apoptosis
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(Marx, 1993).

The oncogenic nature of some bHLH proteins is known to

suppress apoptosis.
antiapoptotic.

For example, TAL 1 bHLH oncoprotein is recently found

A Jurkat leukemic T cell subline expressing a C-terminally

truncated mutant TAL 1 undergoes rapid apoptosis upon medium depletion.
Transfection with a wild type of TAL 1 reverses this process, suggesting that
TAL 1 inhibits the apoptotic signaling in the absence of survival factors (LeroyViard et al., 1995). Overexpression of TAL1 significantly blocks granulopoietic
and monocytic cell apoptosis induced by chemotherapeutic agents (Bernard et
al., 1998). The oncogenic pathology of CCAF is likely due to its antiapoptosis.

CCAF is a gene transcription regulator.
Not all the proteins that possess bHLH domains are transcription factors.

For

example, the calcium binding proteins with the bHLH domain are just
components of the calcium-signaling pathway (Marsden et al, 1990). Thus the
final purpose is to determine if CCAF is a transcription modulator. Firstly, the
nuclear localization provides the evidence that CCAF is a nuclear protein.

Then

the antagonism of CCAF on E47-mediated transactivation further supports that
CCAF is a transcription regulator.

The molecular mechanisms for such an

antagonism remain to be determined. There are three hypotheses: (1) CCAF
binds to the E-box, but the binding doesn't activate transcription; (2) CCAF
sequestrates E47 by forming inactive, non-DNA-binding heterodimers; (3) CCAF
dimerizes with E47 but the heterodimers are less active than E47 homodimers.
E47 is also known a tumor-suppressing protein. The repression on E47 may
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have oncogenic significance. This has been confirmed in oncoproteins such as
Tal1, which forms heterodimers with E47 (Steven et al., 1998).

In summary, the results in the thesis support our overall hypothesis that CCAF is
a transcriptional modulator involving the regulation of cell cycle events, and the
expression of CCAF is related to oncogenic pathology.

However, further

experiments need to be conducted to fully understand CCAF from the structure,
the function and its molecular basis.

The electrophoretic gel mobility assay

(EGMA) can be used to study whether the DNA-binding is required for the
transcription repression (E-box and/or N-box transactivation).

The gene array

can be used to study the target genes regulated by CCAF, and the yeast twohybrid system can be used to study the CCAF mediated protein-protein
interaction. These studies will likely define whether CCAF is a marker for colon
tumor diagnosis and whether CCAF is a potential target for the therapeutic
intervention.
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APPENDIX

ISOLATION OF MULTIPLE DISTINCT cDNAs
BY A SINGLE CDNA-TRAPPING PROCEDURE

Maowen Hu and Bingfang Yan
(Published in 1999, Analytical Biochemistry 266, 233-235)

Screening of a cDNA library is primarily conducted with nuclei acid hybridization
or antibody staining.

These procedures usually involve library plating, colony

transferring to a membrane, and clone identification. Because of the high density
at which clones are plated, isolation of pure clones requires secondary and
multiple screening at decreasing alone densities.

In addition, screening of a

meaningful number (10 5-10 6 ) of cloned may take weeks or even months
(Sambrook et al., 1989).

Recently a cDNA trapping method was developed (Li et al., 1995).

In this

method, a complex population of double-stranded phagemid DNA is isolated
from a cDNA library and converted to single-stranded DNA (ssDNA).

An

oligonucleotide complementary to a segment of the target cDNA is synthesized
and biotinylated. The biotin-labeled oligonucleotide is then subjected to
hybridization with the ssDNAs in solution, and the duplexes are captured on
streptavidin-coated paramagnetic bead. The captured ssDNAs are then released
from the beads, repaired with a polymerase, and transformed into bacteria. This
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method, compared with nucleic acid hybridization and antibody staining, can
screen a large number of clones and isolate full-length cDNA within days.

This report describes a modified cDNA trapping procedure, in which several
oligonucleotides and ssDNAs from more than one library were included in a
single captured reaction.

These oligonucleotides were targeted to distinct

cDNAs. As a result, full-length cDNAs encoding different proteins were isolated
by a single trapping procedure.

Using this method, we successfully isolated

several cDNAs encoding different human cytochrome P450 enzymes and
multiple forms of kinase, which phosphorylate the inositol ring. This modification
significantly reduces cost and time, which is particularly useful for isolating
multiple forms of cDNAs.

Materials and methods. GeneTrapper cDNA kit, human liver and mouse brain
cDNA libraries, and DH10B Escherichia coli (E. colt) were purchased from
GibcoBRL (Gaithersburg,

MD). All oligonucleotides were synthesized by

Genemed Synthesis Inc. (South San Franciscon, CA), and their sequences are
listed in Table 1. Unless otherwise indicated, all other reagents were purchased
from Sigma (St. Louis, MO).

The phagemid libraries were grown in 100 ml Luria broth containing 100 µg/ml
ampicillin with 1 x 106 independent clones to saturation at 30°C (-16h). The
bacterial cells were then centrifuged at 4800g for 15 min at 4°C. The pellet was
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resuspended in 10 ml buffer I containing 15 mM Tris-HCI (pH8.0), 10 mM EDTA,
RNase A (100 µg/ml), and RNase T1 (1200 units/ml). Bacterial cells were lysed
by adding 10 ml buffer II containing 0.2 M Na OH and 1% SOS. The solution was
then neutralized by adding 10 ml of ice-cold 7.5 M NH40ac, mixed gently by
inverting the tubes five times, and incubated on ice for 10 min. The supernatant
was prepared by centrifuging at 3000g for 15 min at 4C and filtered through
cheesecloth. Phagemid DNA was then precipitated by adding an equal amount
of cold isopropanol and centrifuging at 5000g for 15 min at 4C. The DNA pellet
was resuspended in 1 ml buffer I and centrifuged at 12,000g for 1 min at 4C.
The DNA sample was incubated at 37C for 15 min and extracted with an equal
volume of phenol:chloroform:isoamyl alcohol (25:24:1) four times. The phagemid
DNA in the aqueous phase was mixed with an equal volume of isopropanol
followed by centrifugation at 14,000g for 15 min at 4°C. The pellet was then
washed once with 500 µI of 70% ethanol and left to air dry for 15 min at room
temperature. The DNA was then dissolved in 200 µI TE buffer [10 mM Tris-HCI
(pH8.0), 1 mM EDTA] and stored at -29°C until use.

Two groups with a total of six oligonucleotides were synthesized (Table1 ): one
group (P450 group) was targeted to human cytochrome P4502C8, P4502E 1, and
P45 reductase, respectively; and the other group (kinase group) was targeted to
mouse type I phosphatidylinoditol 4-phosphate 5-kinases (Pl4P5 kinase), a and f3
and human inositol 1,3,4-trisphosphate 5/6-kinase [Ins (1,3,4) P3 5/6-kinase],
respectively.

Oligonucleotides were

purified
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by

16% polyacrylamide

gel

electrophoresis (Vorndam et al., 1986). The oligonucleotides (1 µg each) in the
same group were then mixed and biotinylated in a total volume of 25 µI with
biotin-14-dCTP and terminal deoxynucleotidyl transferase as described by the
manufacturer.

Double-stranded phagemid DNA was converted to ssDNA by a sequential
digestion with Gene II and Exolll, and the ssDNA was denatured at 95C for 1 min
and chilled in ice for 1 min. Hybridization between the ssDNA and biotinylated
oligonucleotides was conducted at 37°C for 1 h with the hybridization buffer
provided by the manufacturer. One hybridization reaction was conducted with
the biotinylated oligonucleotides (20 ng) from the P450 group and the ssDNAs
(2.5 µg) from the human liver library, whereas the other hybridization was
conducted with the biotinylated oligonucleotides (20 ng) from the kinase group
and a mixture of the ssDNAs from both the human liver and mouse brain libraries
(1.25 µg each).
polymerase.

The hybridized ssDNAs were repaired by a thermostable

These procedures were conducted

as described

by the

manufacturer.

The repaired captured DNAs (-20% of total) were used to transform DH10B E.
coli (23 µI) with a Cell Porator electroporation system at a field strength of 16.6

kV/cm and a pulse length of 4 ms (GibcoBRL, Gaithersburg, MD).

The

electroporated cells were incubated at 37°C overnight. Individual colonies were
grown in 5 ml of Lauri broth, the phagemid DNA was isolated with a QIAprep
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Spin Miniprep kit (QIAGEN Inc., Santa Clarita, CA) and sequences of the
captured DNAs were determined with an EXCEL II DNA sequencing kit from
Epicentre Technologies (Madison, WI) as described previously (Yan et al., 1995).

Results and discussion.

Oligonucleotides in the P450 group were targeted to

human cytochrome P4502C8, P4502E1, and P450 reductase, respectively.
They were designed to anneal to the 5'-coding region of each cDNA.

The

trapping experiment with these oligonucleotides results in the isolation of -500
individual clones.

From those, 32 individual clones were cultured and the

corresponding phagemid DNAs were isolated. Sequencing of the 5'-end (-350
bases long) demonstrated that they all contained full-length cDNA inserts.
Among them, 6 clones contained the cDNA encoding P4502C8, 4 clones
contained the cDNA encoding P4502C18, and 16 clones contained the cDNA
encoding P4502E1, as shown in Table 2.

Therefore, half of the sequenced

clones contained the cDNA encoding P4502E1.

The P4502C subfamily has four members: they are used in this experiment for
this subfamily matched the sequence of 2C8 perfectly, but did not match the
sequence of 2C9, 2C18, or 2C19 by two bases.

As expected, the trapping

experiment isolated the cDNA encoding 2C8. However, surprisingly the trapping
experiment also isolated the cDNA encoding 2C18 but not 2C9 and 2C19. The
reason for this phenomenon was probably due to the relative abundance of the
cDNA in this library. Namely, the cDNA encoding 2C18 was more abundant in
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this library than those encoding either 2C9 or 2C19. Similarly, a relatively high
abundance of 2E1 cDNA in the library was probably the reason that 50% of the
clones sequenced in the P450 group contained the cDNA encoding this enzyme.
Compared with other P45 enzymes, P4502E1 is not a very abundant enzyme in
normal liver (only -9% of total P450). However, the level of P4502E1 can be
significantly increased by environmental factors such as alcohol consumption
and disease status such as diabetes. It is likely that the individual whose liver
mRNA was used for the constriction of this library was previously exposed to one
or more of these factors.

In contrast, the trapping experiment with the oligonucleotides in kinase group
yielded only 31 individual clones.

As shown in Table 3, 2 of these clones

encoded mouse type I Pl4/5-kinase a; 6 of them encoded mouse type I Pl4/5kinase 13; 4 of them encoded a recently identified type I Pl4P5-kinase, termed y;
and 7 of them encoded human Ins (1,3,4) P3 5/6-kinase.
clones encoded other proteins.

The rest of these

Form y exhibits a high degree of sequence

identity (20 of 21 bases) with form 13 in the region where the oligonucleotide was
derived.

Thus, the cDNA encoding form y was probably captured by the

oligonucleotide for form 13. It should be noted that the human liver and mouse
brain libraries were constructed with vectors that have different flanking
sequences at the polylinker region, which was used to establish by the
polymerase chain reaction which library was the source from which a cDNA was
isolated.
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Among the cONAs encoding other proteins in the kinase group, half coded for
vitamin 0-binding protein (Table 3), and the rest apparently coded for yet
unidentified proteins based on a BLST search in Gene Bank. These unidentified
proteins

may

actually

share

a

significant

sequence

identity with

the

oligonucleotides used for the trapping experiment (only a -350-bp sequence in
the 5' end was determined), which probably contributed to their isolated.

In

contrast, the cONA encoding vitamin 0-binding protein shows no significant
sequence identity with the oligonucleotides; the reason for its isolation remains to
be determined.

It was likely that the abundance of the cONAs coding for the

kinases to be isolated in these libraries was so low that an excess of the labeled
oligonucleotides was available to hybridize with unrelated cONAs and yields false
positives. This notion if supported by the fact that all of the sequenced clones in
the P450 trapping experiment resulted in the isolation of target cONAs, because
P450 enzymes, the primary phase I drug-metabolizing enzymes, are very
abundant in the liver (Shephard et al., 1992).

We report here a modified cONA trapping technique that can accommodate
multiple oligonucleotides and more than one library at the same time.

This

method has all the features of the original method such as screening of a large
number of clones within a week, rapid isolation of full-length cONA, and
identification of related sequences. This modified method, compared with the
original method, saves time and significantly reduces the cost, as the reagent
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used for cDNA trapping are expensive. This is particularly effective for isolating
multiple forms of cDNAs.

Table 5. Sequence of oligonucleotides for cDNA trapping
Enzyme

Sequence

Reference

Human cytochrome P4502C8

5'-gtc tat ggt cct gtg ttc acc-3'

5

Human cytochrome P4502E1

5'-gtg gtg atg cac ggc tac aag-3'

11

Human cytochrome P450 reductase

5'-cag cat gac ggc cat gat tct-3'

12

Mouse Pl-4-phosphat 5-kinase a

5'-caa tgg gag gca ttc cag cta-3'

8

5'-caa gac eta tgc ace tgt tgc-3'

9

5'-atc ate cac aag ctg act gac-3'

10

Mouse Pl-4-phosphate 5-kinase

p

Inositol 1,3,4-triphosphate 5/6-kinase

Table 6. cDNA trapping of human cytochrome P450 enzymes and reductase
Enzyme

Number of positive clones

% of clones sequenced

P4502C8

6

19

P4502C18

4

13

P4502E1

16

50

P450 reductase

6

18

Table 7. cDNA trapping of Pl-4-phospate 5-kinse and
inositol 1,3,4-triphosphate 5/6-kinase
Enzyme

Number of positive clones

% of clones sequenced

2

6

p

6

20

Mouse Pl-4-phosphate 5-kinase y

4

13

Inositol 1,3,4-triphosphate 5/6-kinase

7

23

Others

12

38

Mouse Pl-4-phosphat 5-kinase a
Mouse Pl-4-phosphate 5-kinase
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